Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients

American Journal of Geriatric Psychiatry

Volumn 10, Issue 5, 2002, Pages 541-550

  Schatzberg, Alan F ^a   Kremer, Charlotte ^b   Rodrigues, Heidi E ^b   Murphy, Greer M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Organon Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIRTAZAPINE; PAROXETINE;

AGED; ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FATIGUE; FEMALE; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OBESITY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; SLEEP DISORDER; SOMATIZATION; SOMNOLENCE; VERTIGO; VOMITING; WEIGHT GAIN;

EID: 84903124778     PISSN: 10647481     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019442-200209000-00007     Document Type: Article

References (35)

1. The effectiveness of the treatment of depression in the physically ill elderly
2. Practical considerations for the treatment of depression in elderly and very elderly long-term care patients
3. Efficacy and safety of the selective serotonin reuptake inhibitors in treating depression in elderly patients
4. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized, controlled trial in patients older than 59 years
5. Treatment of geriatric depression
6. The pharmacologic profile of mirtazapine
7. 2-adrenoreceptor antagonist Org 3770 enhances serotonin transmission in vivo
8. Metaanalysis of randomized, double-blind, placebo-controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression
9. Mirtazapine: A review of its use in major depression
10. A metaanalysis of eight randomized, doubleblind controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety
11. Clinical pharmacokinetics of mirtazapine
12. The clinical relevance of preclinical data: Mirtazapine, a model compound
13. Mirtazapine in elderly inpatients with somatic or neurological comorbidity
14. Efficacy and tolerability of mirtazapine used by elderly depressed patients in The Netherlands
15. A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients
16. Org 3770 (mirtazapine) versus trazodone: A placebocontrolled trial in depressed elderly patients
17. Population-based norms for the Mini-Mental State Exam by age and educational level
18. A rating scale for depression
19. When at first you don't succeed: Sequential strategies for antidepressant nonresponders
20. Mirtazapine: Efficacy and tolerability in comparison with fluoxetine in patients with moderate-to-severe major depressive disorder
21. Efficacy and tolerability of mirtazapine versus citalopram: A double-blind, randomized study in patients with major depressive disorder
22. Mirtazapine compared to paroxetine in major depression
23. Care of depressed patients with anxiety symptoms
24. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly
25. A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients
26. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-Week outcome
27. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life
28. A double-blind study of paroxetine compared with fluoxetine in patients with major depression
29. Comparative efficacy of sertraline and fluoxetine in patients age 70 or over with major depression
30. Treatment-resistant depression in late life
31. Comparative efficacy and safety of sertraline versus nortriptyline for major depression in patients 70 and older
32. A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients
33. Paroxetine: Pharmacokinetic and antidepressant effect in the elderly
34. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia